Gilead Sciences, Inc.
THIADIAZOLE IRAK4 COMPOUNDS
Last updated:
Abstract:
A compound of Formula (I): ##STR00001## pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.
Status:
Application
Type:
Utility
Filling date:
13 Aug 2019
Issue date:
12 Mar 2020